[PDF][PDF] CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
N Zhang, YD Zhao, XM Wang - European Review for Medical & …, 2020 - europeanreview.org
OBJECTIVE: The specific mechanism of cytokine storm in COVID-19 infected patients is not
clear. This study aims to identify the key genes that cause cytokine storm in COVID-19 …
clear. This study aims to identify the key genes that cause cytokine storm in COVID-19 …
What is currently known about the role of CXCL10 in SARS-CoV-2 infection?
M Gudowska-Sawczuk, B Mroczko - International Journal of Molecular …, 2022 - mdpi.com
Dysregulation of the immune response plays an important role in the progression of SARS-
CoV-2 infection. A “cytokine storm”, which is a phenomenon associated with uncontrolled …
CoV-2 infection. A “cytokine storm”, which is a phenomenon associated with uncontrolled …
CXCL8, CCL2, and CMV seropositivity as new prognostic factors for a severe COVID-19 course
E Pius-Sadowska, A Niedźwiedź, P Kulig… - International journal of …, 2022 - mdpi.com
The exact pathophysiology of severe COVID-19 is not entirely elucidated, but it has been
established that hyperinflammatory responses and cytokine storms play important roles. The …
established that hyperinflammatory responses and cytokine storms play important roles. The …
Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation
Abstract The coronavirus disease 2019 (COVID-19) is an infectious disease that mainly
affects the host respiratory system with~ 80% asymptomatic or mild cases and~ 5% severe …
affects the host respiratory system with~ 80% asymptomatic or mild cases and~ 5% severe …
Interplay of antibody and cytokine production reveals CXCL13 as a potential novel biomarker of lethal SARS-CoV-2 infection
AM Horspool, T Kieffer, BP Russ, MA DeJong, MA Wolf… - Msphere, 2021 - Am Soc Microbiol
The SARS-CoV-2 pandemic is impacting the global population. This study was designed to
assess the interplay of antibodies with the cytokine response in SARS-CoV-2 patients. We …
assess the interplay of antibodies with the cytokine response in SARS-CoV-2 patients. We …
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
M Sugiyama, N Kinoshita, S Ide, H Nomoto… - Gene, 2021 - Elsevier
Abstract COVID-19, a novel coronavirus-related illness, has spread worldwide. Patients with
apparently mild/moderate symptoms can suddenly develop severe pneumonia. Therefore …
apparently mild/moderate symptoms can suddenly develop severe pneumonia. Therefore …
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
NI Lorè, R De Lorenzo, PMV Rancoita, F Cugnata… - Molecular …, 2021 - Springer
Background Host inflammation contributes to determine whether SARS-CoV-2 infection
causes mild or life-threatening disease. Tools are needed for early risk assessment …
causes mild or life-threatening disease. Tools are needed for early risk assessment …
The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner
V Callahan, S Hawks, MA Crawford, CW Lehman… - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
RNA virus that is the causative agent of the Coronavirus disease 2019 (COVID-19) …
RNA virus that is the causative agent of the Coronavirus disease 2019 (COVID-19) …
High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in COVID-19
A Tveita, SL Murphy, JC Holter, AB Kildal… - The Journal of …, 2022 - academic.oup.com
Background Immune dysregulation is a major factor in the development of severe
coronavirus disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 …
coronavirus disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 …
Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling
X Xi, Y Guo, M Zhu, Y Wei, G Li, B Du, Y Wang - Virology journal, 2021 - Springer
Background Chemokine levels in severe coronavirus disease 2019 (COVID-19) patients
have been shown to be markedly elevated. But the role of chemokines in mild COVID-19 …
have been shown to be markedly elevated. But the role of chemokines in mild COVID-19 …